Eagle Pharmaceuticals EGRX
$ 2.14
-39.89%
Quarterly report 2023-Q2
added 08-08-2023
Country |
USA |
IPO year |
2014 |
Industry |
Drug manufacturers |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Scott Tarriff |
Employees in the company |
108 |
Shares |
12.9 M |
Market Cap[1] |
$ 27.7 M |
EBITDA (LTM) |
$ 34.3 M |
P/E (LTM) |
-50.84 |
P/S (LTM) |
1.09 |
EPS (LTM) |
-0.45 |
Other stocks of industry "Drug manufacturers"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.